当前位置:首页 - 行情中心 - 康缘药业(600557) - 财务分析 - 现金流量表

康缘药业

(600557)

  

流通市值:74.39亿  总市值:74.39亿
流通股本:5.66亿   总股本:5.66亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金922,469,512.833,817,735,154.922,712,758,668.071,723,844,181.66
  收到其他与经营活动有关的现金27,531,153.12193,704,198.39149,901,098.29117,947,310.71
  经营活动现金流入小计950,000,665.954,011,439,353.312,862,659,766.361,841,791,492.37
  购买商品、接受劳务支付的现金156,281,959.54660,974,490.89468,856,439.38283,359,381.35
  支付给职工以及为职工支付的现金207,744,867.43715,600,956.38545,390,647.88385,204,801.72
  支付的各项税费108,984,590.94328,513,432.41231,771,114.27154,041,403.1
  支付其他与经营活动有关的现金411,091,765.341,695,758,301.871,270,516,658.45874,837,758.35
  经营活动现金流出小计884,103,183.253,400,847,181.552,516,534,859.981,697,443,344.52
  经营活动产生的现金流量净额65,897,482.7610,592,171.76346,124,906.38144,348,147.85
二、投资活动产生的现金流量:
  收回投资收到的现金6,966,154.96599,243,952.44489,014,448.79388,014,448.79
  取得投资收益收到的现金2,644,358.0810,262,586.574,924,048.574,868,653.23
  处置固定资产、无形资产和其他长期资产收回的现金净额153,513.22,039,975.71,953,146.28179,708
  投资活动现金流入小计9,764,026.24611,546,514.71495,891,643.64393,062,810.02
  购建固定资产、无形资产和其他长期资产支付的现金187,658,018.94521,777,876.87335,663,338.82206,728,048.27
  投资支付的现金-603,600,000493,600,000413,600,000
  投资活动现金流出小计187,658,018.941,125,377,876.87829,263,338.82620,328,048.27
  投资活动产生的现金流量净额-177,893,992.7-513,831,362.16-333,371,695.18-227,265,238.25
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-91,900,000--
  支付其他与筹资活动有关的现金-24,491,555.3923,149,927.5523,172,212.9
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-116,391,555.3923,149,927.5523,172,212.9
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--116,391,555.39-23,149,927.55-23,172,212.9
四、汇率变动对现金及现金等价物的影响-140,556.11-39,997.46-8,216.49-2,001.51
五、现金及现金等价物净增加额-112,137,066.11-19,670,743.25-10,404,932.84-106,091,304.81
  加:期初现金及现金等价物余额2,148,110,744.092,167,781,487.342,167,781,487.342,167,781,487.34
  期末现金及现金等价物余额2,035,973,677.982,148,110,744.092,157,376,554.52,061,690,182.53
补充资料:
  净利润-307,304,612.7-148,708,370.27
  资产减值准备-20,738,802.14--
  固定资产和投资性房地产折旧-171,874,504.78-85,671,153.44
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-171,874,504.78-85,671,153.44
  无形资产摊销-19,353,561.92-10,382,534.04
  长期待摊费用摊销-7,309,177.68-2,557,464.44
  处置固定资产、无形资产和其他长期资产的损失--429,202.97-20,480.39
  固定资产报废损失-1,351,966.28-857,739.65
  财务费用-14,280,881.52-6,038,618.69
  投资损失--10,243,091.06--4,800,451
  递延所得税-185,267.56--4,457,384.06
  其中:递延所得税资产减少-185,267.56--4,457,384.06
  存货的减少-85,548,587.6-87,260,451.13
  经营性应收项目的减少-218,940,916.07--78,605,903.78
  经营性应付项目的增加--224,453,552.68--110,464,615.48
  现金的期末余额-2,148,110,744.09-2,061,690,182.53
  减:现金的期初余额-2,167,781,487.34-2,167,781,487.34
  现金及现金等价物的净增加额--19,670,743.25--106,091,304.81
公告日期2026-04-302026-04-232025-10-312025-08-28
审计意见(境内)标准无保留意见
TOP↑